INTEGRIS Cancer Inst of OK — Oklahoma City, Oklahoma

INTEGRIS Cancer Inst of OK is a clinical research site located in Oklahoma City, Oklahoma, United States 73142.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

INTEGRIS Cancer Inst of OK has participated in 2 clinical trials.

Therapeutic areas: Colorectal Cancer, Lymphocytic Leukemia, Chronic.

Sponsors: Hoffmann-La Roche, Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for INTEGRIS Cancer Inst of OK?

INTEGRIS Cancer Inst of OK has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has INTEGRIS Cancer Inst of OK conducted?

INTEGRIS Cancer Inst of OK has 2 clinical trials on record. Their work covers Colorectal Cancer, Lymphocytic Leukemia, Chronic.

Is INTEGRIS Cancer Inst of OK accredited by Crixeo Health?

INTEGRIS Cancer Inst of OK has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about INTEGRIS Cancer Inst of OK?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.